Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-19
2006-12-19
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S019300, C530S300000, C530S326000, C530S328000
Reexamination Certificate
active
07151088
ABSTRACT:
The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.
REFERENCES:
patent: 5759991 (1998-06-01), Tohdoh et al.
patent: 6140116 (2000-10-01), Dinsmore
patent: 6174862 (2001-01-01), Brenneman
patent: 6225444 (2001-05-01), Shashoua
patent: 6294383 (2001-09-01), Isacson et al.
patent: 6399575 (2002-06-01), Smith et al.
patent: 6541452 (2003-04-01), Hastings
patent: 6559124 (2003-05-01), O'Brien et al.
patent: 6576272 (2003-06-01), Blechman
patent: 1 325 747 (2003-07-01), None
W.L. Kelemen and C.E. Creely. Hum. Psychopharmacol. Clin. Exp. (2001) 16, pp. 309-319.
Illana Gozes et al., “Peptides as Drug Candidates Against Alzheimer's Disease,”Drug Development Research, vol. 56, pp. 475-481 (2002).
X. A. Alvarez et al., “Oral Cerebrolysin® enhances brain alpha activity and improves cognitive performance in elderly control subjects,”J. Neural Transm., Suppl., vol. 59, pp. 315-328 (2000).
K. Bulloch et al., “Calcitonin Gene-Related Peptide Immunoreactivity in the Hippocampus and Its Relationship to Cellular Changes Following Exposure to Trimethyltin,”Journal of Neuroscience Research, vol. 55, pp. 441-457 (1999).
L. Parnetti et al., “Posatirelin in the treatment of vascular dementia: a double-blind multicentre study vs placebo,”Acta. Neurol. Scand., vol. 93, pp. 456-463 (1996).
M. Gonzalez-Gross et al., “Nutrition and cognitive impairment in the elderly,”British Journal of Nutrition, vol. 86, pp. 313-321 (2001).
M. Yoshikawa et al., “Bioactive peptides derived from food proteins preventing lifestyle-related diseases,”BioFactors, vol. 12, pp. 143-146 (2000).
Wick, “Anti-aging medicine does it exist? A critical discussion of anti-aging health products,”Exp. Gerontol., vol. 37, pp. 1137-1140, 2002.
Ueki, “Drug of abuse,”Rinsho Byori, vol. 50, No. 2, pp. 151-155, 2002.
Binstock, “The war on anti-aging medicine,”Gerontologist, vol. 43, No. 1, pp. 4-14, 2003.
Moessler Herbert
Riedl Christa
Schmitzberger Wolfgang
Schnait Heinz
Ebewe Pharma Ges.M.H. Nfg.KG
Kosar Andrew D.
Tsang Cecilia J.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Neuroprotective dietary supplement does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuroprotective dietary supplement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotective dietary supplement will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3719675